Skip to main content
Journal cover image

THE SAFETY AND TOLERABILITY OF MULTIPLE DOSE ADMINISTRATION OF CSL112, AN INTRAVENOUS FORMULATION OF PLASMA-DERIVED APOA-I, AMONG SUBJECTS WITH MODERATE RENAL IMPAIRMENT AFTER ACUTE MYOCARDIAL INFARCTION

Publication ,  Conference
Gibson, CM; Yee, M; Daaboul, Y; Korjian, S; Mehr, AP; Kerneis, M; Tricoci, P; Alexander, J; Kastelein, J; Mehran, R; Bode, C; Lewis, B ...
Published in: Journal of the American College of Cardiology
March 2018

Duke Scholars

Published In

Journal of the American College of Cardiology

DOI

ISSN

0735-1097

Publication Date

March 2018

Volume

71

Issue

11

Start / End Page

A165 / A165

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gibson, C. M., Yee, M., Daaboul, Y., Korjian, S., Mehr, A. P., Kerneis, M., … Merkely, B. (2018). THE SAFETY AND TOLERABILITY OF MULTIPLE DOSE ADMINISTRATION OF CSL112, AN INTRAVENOUS FORMULATION OF PLASMA-DERIVED APOA-I, AMONG SUBJECTS WITH MODERATE RENAL IMPAIRMENT AFTER ACUTE MYOCARDIAL INFARCTION. In Journal of the American College of Cardiology (Vol. 71, pp. A165–A165). Elsevier BV. https://doi.org/10.1016/s0735-1097(18)30706-x
Gibson, C Michael, Megan Yee, Yazan Daaboul, Serge Korjian, Ali Poyan Mehr, Mathieu Kerneis, Pierluigi Tricoci, et al. “THE SAFETY AND TOLERABILITY OF MULTIPLE DOSE ADMINISTRATION OF CSL112, AN INTRAVENOUS FORMULATION OF PLASMA-DERIVED APOA-I, AMONG SUBJECTS WITH MODERATE RENAL IMPAIRMENT AFTER ACUTE MYOCARDIAL INFARCTION.” In Journal of the American College of Cardiology, 71:A165–A165. Elsevier BV, 2018. https://doi.org/10.1016/s0735-1097(18)30706-x.
Gibson CM, Yee M, Daaboul Y, Korjian S, Mehr AP, Kerneis M, et al. THE SAFETY AND TOLERABILITY OF MULTIPLE DOSE ADMINISTRATION OF CSL112, AN INTRAVENOUS FORMULATION OF PLASMA-DERIVED APOA-I, AMONG SUBJECTS WITH MODERATE RENAL IMPAIRMENT AFTER ACUTE MYOCARDIAL INFARCTION. In: Journal of the American College of Cardiology. Elsevier BV; 2018. p. A165–A165.
Gibson, C. Michael, et al. “THE SAFETY AND TOLERABILITY OF MULTIPLE DOSE ADMINISTRATION OF CSL112, AN INTRAVENOUS FORMULATION OF PLASMA-DERIVED APOA-I, AMONG SUBJECTS WITH MODERATE RENAL IMPAIRMENT AFTER ACUTE MYOCARDIAL INFARCTION.” Journal of the American College of Cardiology, vol. 71, no. 11, Elsevier BV, 2018, pp. A165–A165. Crossref, doi:10.1016/s0735-1097(18)30706-x.
Gibson CM, Yee M, Daaboul Y, Korjian S, Mehr AP, Kerneis M, Tricoci P, Alexander J, Kastelein J, Mehran R, Bode C, Lewis B, Mehta R, Duffy D, Feaster J, Halabi M, Angiolillo D, Duerschmied D, Ophius TO, Merkely B. THE SAFETY AND TOLERABILITY OF MULTIPLE DOSE ADMINISTRATION OF CSL112, AN INTRAVENOUS FORMULATION OF PLASMA-DERIVED APOA-I, AMONG SUBJECTS WITH MODERATE RENAL IMPAIRMENT AFTER ACUTE MYOCARDIAL INFARCTION. Journal of the American College of Cardiology. Elsevier BV; 2018. p. A165–A165.
Journal cover image

Published In

Journal of the American College of Cardiology

DOI

ISSN

0735-1097

Publication Date

March 2018

Volume

71

Issue

11

Start / End Page

A165 / A165

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology